Cancer Investigation
Volume 39, 2021 - Issue 10
Open access
1,879
Views
2
CrossRef citations to date
0
Altmetric
Research Article
Phase II Study of Single-Agent and Combination Everolimus and Panobinostat in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Prioty Islama Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina, USAView further author information
, David Rizzieria Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina, USAView further author information
, Chenyu Lina Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina, USAView further author information
, Carlos de Castroa Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina, USAView further author information
, Louis Diehla Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina, USAView further author information
, Zhiguo Lib Duke Cancer Institute, Biostatistics Shared Resources, Duke University, Durham, North Carolina, USAView further author information
, Joseph Moorea Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina, USAView further author information
, Tod Morrisa Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina, USAView further author information
& Anne Beavena Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina, USA;c Division of Hematology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USACorrespondence[email protected]
https://orcid.org/0000-0002-9174-3568View further author information
show allhttps://orcid.org/0000-0002-9174-3568View further author information
Pages 871-879
|
Received 20 Jul 2021, Accepted 16 Sep 2021, Published online: 13 Oct 2021
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.